Literature DB >> 16728713

Contribution of high-mobility group box-1 to the development of ventilator-induced lung injury.

Eileen N Ogawa1, Akitoshi Ishizaka, Sadatomo Tasaka, Hidefumi Koh, Hiroshi Ueno, Fumimasa Amaya, Masahito Ebina, Shingo Yamada, Yosuke Funakoshi, Junko Soejima, Kiyoshi Moriyama, Toru Kotani, Satoru Hashimoto, Hiroshi Morisaki, Edward Abraham, Junzo Takeda.   

Abstract

RATIONALE: Proinflammatory cytokines play an important role in ventilator-induced lung injury (VILI). High-mobility group box-1 (HMGB1) is a macrophage-derived proinflammatory cytokine that can cause lung injury.
OBJECTIVES: This study tested the hypothesis that HMGB1 is released in intact lungs ventilated with large Vt. A second objective was to identify the source of HMGB1. A third objective was to examine the effects of blocking HMGB1 on the subsequent development of VILI.
METHODS: Bronchoalveolar lavage fluid (BALF) and lung tissues were obtained from rabbits mechanically ventilated for 4 h with a small (8 ml/kg) versus a large (30 ml/kg) Vt. BALF was also obtained from rabbits with intratracheal instillation of anti-HMGB1 antibody before the initiation of large Vt ventilation.
MEASUREMENTS AND MAIN RESULTS: The concentrations of HMGB1 in BALF were fivefold higher in the large than in the small Vt group. Immunohistochemistry and immunofluorescence studies revealed expression of HMGB1 in the cytoplasm of macrophages and neutrophils in lungs ventilated with large Vt. Blocking HMGB1 improved oxygenation, limited microvascular permeability and neutrophil influx into the alveolar lumen, and decreased concentrations of tumor necrosis factor-alpha in BALF.
CONCLUSIONS: These observations suggest that HMGB1 could be one of the deteriorating factors in the development of VILI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728713     DOI: 10.1164/rccm.200605-699OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  63 in total

1.  Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis.

Authors:  Hidehiro Sawa; Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Takahiro Nakajima; Yoshikazu Kuroda
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

Review 2.  Alarmins: awaiting a clinical response.

Authors:  James K Chan; Johannes Roth; Joost J Oppenheim; Kevin J Tracey; Thomas Vogl; Marc Feldmann; Nicole Horwood; Jagdeep Nanchahal
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

3.  Dietary advanced glycation end-products, its pulmonary receptor, and high mobility group box 1 in aspiration lung injury.

Authors:  Peter J Smit; Weidun A Guo; Bruce A Davidson; Barbara A Mullan; Jadwiga D Helinski; Paul R Knight
Journal:  J Surg Res       Date:  2014-04-08       Impact factor: 2.192

Review 4.  High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

Authors:  Shu Zhu; Wei Li; Mary F Ward; Andrew E Sama; Haichao Wang
Journal:  Inflamm Allergy Drug Targets       Date:  2010-03

5.  Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway Inflammation.

Authors:  Amit Gaggar; Steven M Rowe; Hardision Matthew; J Edwin Blalock
Journal:  Open Respir Med J       Date:  2010-03-30

6.  HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.

Authors:  Sari Karlsson; Ville Pettilä; Jyrki Tenhunen; Raili Laru-Sompa; Marja Hynninen; Esko Ruokonen
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

Review 7.  Role of monocytes and macrophages in regulating immune response following lung transplantation.

Authors:  Stephen Chiu; Ankit Bharat
Journal:  Curr Opin Organ Transplant       Date:  2016-06       Impact factor: 2.640

8.  Toll-like receptor 4-interacting SPA4 peptide suppresses the NLRP3 inflammasome in response to LPS and ATP stimuli.

Authors:  Vijay Ramani; Shanjana Awasthi
Journal:  J Leukoc Biol       Date:  2015-08-07       Impact factor: 4.962

Review 9.  Targeting HMGB1 in inflammation.

Authors:  Huan Yang; Kevin J Tracey
Journal:  Biochim Biophys Acta       Date:  2009-12-03

10.  HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4.

Authors:  Jean-Marc Tadie; Hong-Beom Bae; Shaoning Jiang; Dae Won Park; Celeste P Bell; Huan Yang; Jean-Francois Pittet; Kevin Tracey; Victor J Thannickal; Edward Abraham; Jaroslaw W Zmijewski
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.